142 filings
Page 6 of 8
8-K
msy4j4fx
7 Jan 19
Regulation FD Disclosure
7:53am
8-K/A
fqkdg ta9zj
20 Dec 18
Departure of Directors or Certain Officers
6:06am
8-K
7ctxehnlxhisybnwtl
13 Dec 18
Entry into a Material Definitive Agreement
7:16am
8-K
lye35y
16 Nov 18
Departure of Directors or Certain Officers
6:10am
8-K
49kwckzht
1 Oct 18
Entry into a Material Definitive Agreement
12:00am
8-K
vlmcd3
28 Aug 18
Departure of Directors or Certain Officers
12:00am
8-K
h368n482cv4v31
28 Jun 18
Entry into a Material Definitive Agreement
7:57am
8-K
jly0c6n4xwmpo7u0
15 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
qlb95p5e t4bt
12 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
8oz29c2
26 Mar 18
Other Events
12:00am
8-K
zvexixd
29 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
6k0nyveqc
21 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
vah0kwsch2
25 May 17
Akebia Therapeutics Names Rita Jain, M.D. as Chief Medical Officer
12:00am
8-K
umctfe pz
15 May 17
Akebia and Vifor Pharma Announce Exclusive License Agreement to Provide Vadadustat to Fresenius Medical Care in the U.S. Upon FDA Approval
12:00am
8-K
u0lffd36wz8cd1jn9ax
25 Apr 17
Akebia and Otsuka Expand Relationship with Collaboration to Develop and Commercialize Vadadustat in Europe, China and Other Territories
12:00am
8-K
vfz4td4x6 79
13 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
hsonls5rhr g1yw
20 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K/A
s8pq3j4kqb a8r4cw
14 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
5zjtn
20 Sep 16
Departure of Directors or Certain Officers
12:00am
8-K
c7h0x5lr5 y72j2p
2 Aug 16
Akebia Therapeutics Appoints Scott A. Canute to its Board of Directors
12:00am